Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 12.11.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | s and Exchange Commission (the “SEC”). Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Ap |
| 27.09.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Co |
| 26.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ge Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Appointment of Certain Officers; Compen |
| 05.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Co |
| 08.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Co |
Stammdaten
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.
Unternehmen & Branche
| Name | AVENUE THERAPEUTICS, INC. |
|---|---|
| Ticker | ATXI |
| CIK | 0001644963 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 1,8 Mio. USD |
| Beta | -0,92 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 1,404,000 | -2,909,000 | 2,931,000 | 1,832,000 | |
| 2025-09-30 | 10-Q | 0 | -683,000 | 3,725,000 | 3,557,000 | |
| 2025-06-30 | 10-Q | 1,404,000 | 335,000 | 4,161,000 | 4,058,000 | |
| 2025-03-31 | 10-Q | -1,852,000 | 3,594,000 | 3,510,000 | ||
| 2024-12-31 | 10-K | 0 | -11,652,000 | 2,672,000 | 2,797,000 | |
| 2024-09-30 | 10-Q | 0 | -3,076,000 | 2,625,000 | 2,610,000 | |
| 2024-06-30 | 10-Q | 0 | -2,692,000 | 4,988,000 | 4,764,000 | |
| 2024-03-31 | 10-Q | -4,340,000 | 3,310,000 | 2,836,000 | ||
| 2023-09-30 | 10-Q | 526,000 | 0.06 | 502,000 | -3,650,000 | |
| 2023-06-30 | 10-Q | -4,007,000 | 1,666,000 | -5,336,000 | ||
| 2022-12-31 | 10-K | -3,552,000 | 6,845,000 | 3,905,000 | ||
| 2022-09-30 | 10-Q | -662,000 | -0.45 | 575,000 | -39,000 | |
| 2022-06-30 | 10-Q | -604,000 | -0.03 | 1,005,000 | 598,000 | |
| 2022-03-31 | 10-Q | -2,861,000 | -0.14 | 1,956,000 | 1,159,000 | |
| 2021-12-31 | 10-K | -3,731,000 | -0.22 | 3,960,000 | 3,451,000 | |
| 2021-09-30 | 10-Q | -871,000 | -0.79 | 688,000 | -160,000 | |
| 2021-06-30 | 10-Q | -949,000 | -0.06 | 1,191,000 | 642,000 | |
| 2021-03-31 | 10-Q | -998,000 | -0.06 | 1,944,000 | 1,475,000 | |
| 2020-12-31 | 10-K | -5,151,000 | -0.31 | 3,245,000 | 2,359,000 | |
| 2020-09-30 | 10-Q | -1,028,000 | -0.06 | 4,352,000 | 3,234,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.